New York, New York (PRWEB) September 01, 2013
Biomet hip lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims involving the M2a Magnum Hip Replacement System continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to court documents, the litigation’s next Case Management Conference has been scheduled for September 23, 2013. Deadlines for dispositive motions and selection of bellwether cases are among the issues set to be discussed at that conference. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are pleased to see this litigation moving forward, as our Firm continues to hear from Biomet hip replacement recipients who suffered serious complications, allegedly due to the metal-on-metal design of the M2a Magnum hip,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by an M2a Magnum hip.
Biomet Hip Replacement Lawsuits
According to court documents, nearly 600 Biomet hip replacement lawsuits are now pending in the federal litigation underway in Indiana. Plaintiffs in these lawsuits claim that the M2a Magnum hip can shed dangerous amounts of metal debris due to wear of its metal components, leading to metallosis, chronic pain, premature failure, and other serious complications that may result in the need for revision surgery to replace the allegedly defective hip implant.
Metal-on-metal hip implants, like the Biomet M2a Magnum, have been the subject of a U.S.
Food & Drug Administration (FDA) investigation since February 2011. On January 17, 2013, the FDA cautioned that these types of artificial hips appeared to be associated with higher rates of premature failure and revision surgery compared to those made with other materials. The agency has advised recipients of metal-on-metal hip implants to undergo metal ion blood testing if they were experiencing symptoms of hip failure. The FDA is also considering new regulations that, if adopted, would subject all-metal implants to greater regulatory scrutiny
Patients implanted with the Biomet M2a Magnum hip may be entitled to compensation if they experienced metallosis, chronic pain, early failure of the implant, or other serious complications. Learn More about this Biomet hip replacement at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP